Is Resverlogix Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Resverlogix Corp (RVX.TO) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Resverlogix Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Resverlogix Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Resverlogix Corp?

Muslim investors may consider investing in Resverlogix Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Resverlogix Corp classified as NOT HALAL?

Musaffa determines the Shariah status of Resverlogix Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Resverlogix Corp updated?

The Shariah compliance status of Resverlogix Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Resverlogix Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Resverlogix Corp?

You can check the latest Shariah compliance status of Resverlogix Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

RVX.TO Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 15, 2025

Report Source: 2025 1st Quarter Report

Analyst's Ratings for Resverlogix Corp (RVX.TO)

Based on 5 analysts giving stock ratings to Resverlogix Corp in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Resverlogix Corp. Stock Analysis RVX.TO

Canada Health Care Nano Cap Report: Q1, 2025

Resverlogix Corp. engages in the research and development of pharmaceutical products for cardiovascular diseases. The firm focuses on the development of a new class of therapeutics: bromodomain and extraterminal domain (BET) protein inhibitors. BET proteins play a central role in epigenetics and enable the transcription of disease-causing genes. Its small molecule BET inhibitors are designed to exploit this central epigenetic role to regulate gene expression and tackle the root causes of chronic diseases. The firm's clinical program focuses on evaluating the lead epigenetic candidate apabetalone for the treatment of cardiovascular disease, associated comorbidities, and post-COVID-19 conditions. The company partners with EVERSANA to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

Key Statistics of Resverlogix Corp (RVX.TO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.10CAD0.10

Today's Open

CAD0.10

Volume

4000.00

P/E Ratio (TTM)

52 Week Range

CAD0.04CAD0.30

Market Cap

31.62M

Avg. Volume

15.75K

Dividend Yield

Financial Metrics & Statements of Resverlogix Corp (RVX.TO)

FAQ's for Resverlogix Corp (RVX.TO)

According to Musaffa’s Shariah screening methodology, Resverlogix Corp (RVX.TO) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.